nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Stridor—Hyoscyamine—pancreatitis	0.0709	0.0713	CcSEcCtD
Salmeterol—Dermatitis atopic—Propantheline—pancreatitis	0.061	0.0613	CcSEcCtD
Salmeterol—Keratitis—Hyoscyamine—pancreatitis	0.0356	0.0358	CcSEcCtD
Salmeterol—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.0353	0.0355	CcSEcCtD
Salmeterol—Heartburn—Hyoscyamine—pancreatitis	0.0336	0.0338	CcSEcCtD
Salmeterol—Laryngitis—Hyoscyamine—pancreatitis	0.0321	0.0322	CcSEcCtD
Salmeterol—Laryngospasm—Hyoscyamine—pancreatitis	0.031	0.0311	CcSEcCtD
Salmeterol—Extrasystoles—Hyoscyamine—pancreatitis	0.0275	0.0276	CcSEcCtD
Salmeterol—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.0231	0.0232	CcSEcCtD
Salmeterol—Dermatitis contact—Hyoscyamine—pancreatitis	0.0228	0.023	CcSEcCtD
Salmeterol—Hyperkinesia—Hyoscyamine—pancreatitis	0.0202	0.0203	CcSEcCtD
Salmeterol—Tension—Propantheline—pancreatitis	0.0194	0.0195	CcSEcCtD
Salmeterol—Nervousness—Propantheline—pancreatitis	0.0192	0.0193	CcSEcCtD
Salmeterol—Swelling—Hyoscyamine—pancreatitis	0.019	0.0191	CcSEcCtD
Salmeterol—Eczema—Hyoscyamine—pancreatitis	0.0187	0.0188	CcSEcCtD
Salmeterol—Nasal congestion—Hyoscyamine—pancreatitis	0.0184	0.0185	CcSEcCtD
Salmeterol—Atrial fibrillation—Hyoscyamine—pancreatitis	0.0177	0.0178	CcSEcCtD
Salmeterol—Palpitations—Propantheline—pancreatitis	0.0174	0.0175	CcSEcCtD
Salmeterol—Dry mouth—Propantheline—pancreatitis	0.0164	0.0165	CcSEcCtD
Salmeterol—Anaphylactic shock—Propantheline—pancreatitis	0.0161	0.0162	CcSEcCtD
Salmeterol—Irritability—Hyoscyamine—pancreatitis	0.016	0.0161	CcSEcCtD
Salmeterol—Tachycardia—Propantheline—pancreatitis	0.0157	0.0158	CcSEcCtD
Salmeterol—Insomnia—Propantheline—pancreatitis	0.0146	0.0147	CcSEcCtD
Salmeterol—Constipation—Propantheline—pancreatitis	0.0138	0.0139	CcSEcCtD
Salmeterol—Feeling abnormal—Propantheline—pancreatitis	0.0133	0.0133	CcSEcCtD
Salmeterol—Hyperglycaemia—Hyoscyamine—pancreatitis	0.0131	0.0132	CcSEcCtD
Salmeterol—Urticaria—Propantheline—pancreatitis	0.0128	0.0129	CcSEcCtD
Salmeterol—Conjunctivitis—Hyoscyamine—pancreatitis	0.0126	0.0126	CcSEcCtD
Salmeterol—Hypersensitivity—Propantheline—pancreatitis	0.0119	0.0119	CcSEcCtD
Salmeterol—Asthenia—Propantheline—pancreatitis	0.0116	0.0116	CcSEcCtD
Salmeterol—Dizziness—Propantheline—pancreatitis	0.0107	0.0107	CcSEcCtD
Salmeterol—Arrhythmia—Hyoscyamine—pancreatitis	0.0104	0.0104	CcSEcCtD
Salmeterol—Vomiting—Propantheline—pancreatitis	0.0102	0.0103	CcSEcCtD
Salmeterol—Mental disorder—Hyoscyamine—pancreatitis	0.0102	0.0102	CcSEcCtD
Salmeterol—Rash—Propantheline—pancreatitis	0.0102	0.0102	CcSEcCtD
Salmeterol—Dermatitis—Propantheline—pancreatitis	0.0101	0.0102	CcSEcCtD
Salmeterol—Headache—Propantheline—pancreatitis	0.0101	0.0101	CcSEcCtD
Salmeterol—Tension—Hyoscyamine—pancreatitis	0.00991	0.00997	CcSEcCtD
Salmeterol—Nervousness—Hyoscyamine—pancreatitis	0.00981	0.00987	CcSEcCtD
Salmeterol—Nausea—Propantheline—pancreatitis	0.00957	0.00962	CcSEcCtD
Salmeterol—Agitation—Hyoscyamine—pancreatitis	0.00929	0.00934	CcSEcCtD
Salmeterol—Angioedema—Hyoscyamine—pancreatitis	0.00923	0.00928	CcSEcCtD
Salmeterol—Palpitations—Hyoscyamine—pancreatitis	0.00893	0.00898	CcSEcCtD
Salmeterol—Chest pain—Hyoscyamine—pancreatitis	0.0086	0.00865	CcSEcCtD
Salmeterol—Anxiety—Hyoscyamine—pancreatitis	0.00857	0.00862	CcSEcCtD
Salmeterol—Dry mouth—Hyoscyamine—pancreatitis	0.00841	0.00846	CcSEcCtD
Salmeterol—Oedema—Hyoscyamine—pancreatitis	0.00825	0.00829	CcSEcCtD
Salmeterol—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00825	0.00829	CcSEcCtD
Salmeterol—Tachycardia—Hyoscyamine—pancreatitis	0.00805	0.00809	CcSEcCtD
Salmeterol—Insomnia—Hyoscyamine—pancreatitis	0.00746	0.0075	CcSEcCtD
Salmeterol—Dyspnoea—Hyoscyamine—pancreatitis	0.00735	0.00739	CcSEcCtD
Salmeterol—Dyspepsia—Hyoscyamine—pancreatitis	0.00726	0.0073	CcSEcCtD
Salmeterol—Fatigue—Hyoscyamine—pancreatitis	0.00711	0.00715	CcSEcCtD
Salmeterol—Constipation—Hyoscyamine—pancreatitis	0.00705	0.00709	CcSEcCtD
Salmeterol—Pain—Hyoscyamine—pancreatitis	0.00705	0.00709	CcSEcCtD
Salmeterol—Feeling abnormal—Hyoscyamine—pancreatitis	0.0068	0.00683	CcSEcCtD
Salmeterol—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00674	0.00678	CcSEcCtD
Salmeterol—Urticaria—Hyoscyamine—pancreatitis	0.00655	0.00659	CcSEcCtD
Salmeterol—Body temperature increased—Hyoscyamine—pancreatitis	0.00652	0.00656	CcSEcCtD
Salmeterol—Abdominal pain—Hyoscyamine—pancreatitis	0.00652	0.00656	CcSEcCtD
Salmeterol—Hypersensitivity—Hyoscyamine—pancreatitis	0.00608	0.00611	CcSEcCtD
Salmeterol—Asthenia—Hyoscyamine—pancreatitis	0.00592	0.00595	CcSEcCtD
Salmeterol—Diarrhoea—Hyoscyamine—pancreatitis	0.00564	0.00567	CcSEcCtD
Salmeterol—Dizziness—Hyoscyamine—pancreatitis	0.00545	0.00548	CcSEcCtD
Salmeterol—Vomiting—Hyoscyamine—pancreatitis	0.00524	0.00527	CcSEcCtD
Salmeterol—Rash—Hyoscyamine—pancreatitis	0.0052	0.00523	CcSEcCtD
Salmeterol—Dermatitis—Hyoscyamine—pancreatitis	0.00519	0.00522	CcSEcCtD
Salmeterol—Headache—Hyoscyamine—pancreatitis	0.00517	0.00519	CcSEcCtD
Salmeterol—Nausea—Hyoscyamine—pancreatitis	0.0049	0.00493	CcSEcCtD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000157	0.0281	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000146	0.0261	CbGpPWpGaD
Salmeterol—CYP3A5—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00014	0.0251	CbGpPWpGaD
Salmeterol—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00013	0.0233	CbGpPWpGaD
Salmeterol—CYP2C8—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.000121	0.0217	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000113	0.0203	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000109	0.0195	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000105	0.0189	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	9.83e-05	0.0176	CbGpPWpGaD
Salmeterol—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	9.15e-05	0.0164	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	9.13e-05	0.0164	CbGpPWpGaD
Salmeterol—ADRB2—Arf6 signaling events—HGF—pancreatitis	9.05e-05	0.0162	CbGpPWpGaD
Salmeterol—ADRB2—Monoamine GPCRs—HTR2A—pancreatitis	8.39e-05	0.015	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—FDX1—pancreatitis	8.34e-05	0.0149	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	7.86e-05	0.0141	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—ADH4—pancreatitis	7.75e-05	0.0139	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	7.66e-05	0.0137	CbGpPWpGaD
Salmeterol—ADRB2—Arf6 signaling events—MET—pancreatitis	7.14e-05	0.0128	CbGpPWpGaD
Salmeterol—ADRB2—Amine ligand-binding receptors—HTR2A—pancreatitis	7.06e-05	0.0126	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	6.81e-05	0.0122	CbGpPWpGaD
Salmeterol—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	6.51e-05	0.0117	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—SMO—pancreatitis	6.46e-05	0.0116	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—SCT—pancreatitis	6.38e-05	0.0114	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—FDX1—pancreatitis	6.03e-05	0.0108	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—ADH1B—pancreatitis	5.78e-05	0.0103	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—ADH4—pancreatitis	5.6e-05	0.01	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	5.54e-05	0.00992	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—CNR1—pancreatitis	5.46e-05	0.00977	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	5.27e-05	0.00945	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—FDX1—pancreatitis	5.22e-05	0.00935	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—PTHLH—pancreatitis	5.05e-05	0.00904	CbGpPWpGaD
Salmeterol—ADRB2—Arf6 trafficking events—INS—pancreatitis	5.02e-05	0.009	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	4.9e-05	0.00878	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ADH4—pancreatitis	4.85e-05	0.00869	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	4.8e-05	0.00859	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—ADH1B—pancreatitis	4.18e-05	0.00748	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—GCG—pancreatitis	4.11e-05	0.00737	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—ALDH2—pancreatitis	4.07e-05	0.00729	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	3.94e-05	0.00706	CbGpPWpGaD
Salmeterol—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	3.93e-05	0.00704	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—HTR2A—pancreatitis	3.73e-05	0.00668	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	3.66e-05	0.00655	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ADH1B—pancreatitis	3.62e-05	0.00648	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	3.39e-05	0.00607	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	3.3e-05	0.00592	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	3.25e-05	0.00582	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—PPY—pancreatitis	3e-05	0.00537	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	2.99e-05	0.00535	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—ALDH2—pancreatitis	2.94e-05	0.00527	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	2.9e-05	0.0052	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	2.9e-05	0.0052	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	2.83e-05	0.00507	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	2.83e-05	0.00507	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—FDX1—pancreatitis	2.8e-05	0.00502	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	2.78e-05	0.00499	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ADH4—pancreatitis	2.6e-05	0.00466	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	2.58e-05	0.00461	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—ALDH2—pancreatitis	2.55e-05	0.00457	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	2.42e-05	0.00433	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	2.37e-05	0.00425	CbGpPWpGaD
Salmeterol—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatitis	2.34e-05	0.00419	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—SCT—pancreatitis	2.32e-05	0.00415	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CASR—pancreatitis	2.32e-05	0.00415	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CX3CL1—pancreatitis	2.27e-05	0.00407	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—MTNR1B—pancreatitis	2.21e-05	0.00396	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCK—pancreatitis	2.21e-05	0.00396	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	2.2e-05	0.00394	CbGpPWpGaD
Salmeterol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	2.17e-05	0.00389	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CNR2—pancreatitis	2.15e-05	0.00386	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—TACR1—pancreatitis	2.15e-05	0.00386	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCKAR—pancreatitis	2.12e-05	0.0038	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	2.07e-05	0.00371	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	2.03e-05	0.00364	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	2e-05	0.00359	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ADH1B—pancreatitis	1.94e-05	0.00348	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	1.88e-05	0.00337	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—PTHLH—pancreatitis	1.83e-05	0.00328	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—SMO—pancreatitis	1.83e-05	0.00328	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PPY—pancreatitis	1.7e-05	0.00304	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—SST—pancreatitis	1.68e-05	0.003	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	1.66e-05	0.00297	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CTRB2—pancreatitis	1.64e-05	0.00294	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	1.62e-05	0.0029	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—BDKRB2—pancreatitis	1.58e-05	0.00282	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	1.57e-05	0.00282	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CNR1—pancreatitis	1.55e-05	0.00277	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PPY—pancreatitis	1.54e-05	0.00276	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—GCG—pancreatitis	1.49e-05	0.00268	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—KNG1—pancreatitis	1.43e-05	0.00257	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—FDX1—pancreatitis	1.43e-05	0.00255	CbGpPWpGaD
Salmeterol—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	1.39e-05	0.00249	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	1.39e-05	0.00249	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—ALDH2—pancreatitis	1.37e-05	0.00245	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH4—pancreatitis	1.33e-05	0.00237	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—SCT—pancreatitis	1.31e-05	0.00235	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CASR—pancreatitis	1.31e-05	0.00235	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCK—pancreatitis	1.25e-05	0.00224	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—MTNR1B—pancreatitis	1.25e-05	0.00224	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PRSS1—pancreatitis	1.25e-05	0.00223	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CNR2—pancreatitis	1.22e-05	0.00218	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—TACR1—pancreatitis	1.22e-05	0.00218	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL5—pancreatitis	1.2e-05	0.00215	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCKAR—pancreatitis	1.2e-05	0.00215	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—SCT—pancreatitis	1.19e-05	0.00213	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CASR—pancreatitis	1.19e-05	0.00213	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CTRB2—pancreatitis	1.19e-05	0.00213	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PRSS3—pancreatitis	1.18e-05	0.00212	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PNLIP—pancreatitis	1.18e-05	0.00212	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CX3CL1—pancreatitis	1.17e-05	0.00209	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—MTNR1B—pancreatitis	1.13e-05	0.00203	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCK—pancreatitis	1.13e-05	0.00203	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	1.11e-05	0.00198	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CNR2—pancreatitis	1.11e-05	0.00198	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—TACR1—pancreatitis	1.11e-05	0.00198	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCKAR—pancreatitis	1.09e-05	0.00195	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	1.08e-05	0.00194	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—A2M—pancreatitis	1.07e-05	0.00192	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—XDH—pancreatitis	1.06e-05	0.0019	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—pancreatitis	1.06e-05	0.00189	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PTHLH—pancreatitis	1.04e-05	0.00185	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—FDX1—pancreatitis	1.03e-05	0.00185	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CTRB2—pancreatitis	1.03e-05	0.00184	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PNLIP—pancreatitis	1.01e-05	0.00182	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADH1B—pancreatitis	9.88e-06	0.00177	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH4—pancreatitis	9.58e-06	0.00172	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—SST—pancreatitis	9.47e-06	0.0017	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PTHLH—pancreatitis	9.4e-06	0.00168	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—SMO—pancreatitis	9.4e-06	0.00168	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPY—pancreatitis	9.09e-06	0.00163	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PRSS1—pancreatitis	9.01e-06	0.00161	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PPP3CA—pancreatitis	8.97e-06	0.00161	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FDX1—pancreatitis	8.93e-06	0.0016	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—BDKRB2—pancreatitis	8.9e-06	0.00159	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CNR1—pancreatitis	8.74e-06	0.00157	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—SST—pancreatitis	8.6e-06	0.00154	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	8.57e-06	0.00154	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PNLIP—pancreatitis	8.54e-06	0.00153	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PRSS3—pancreatitis	8.54e-06	0.00153	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—GCG—pancreatitis	8.44e-06	0.00151	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH4—pancreatitis	8.3e-06	0.00149	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL2—pancreatitis	8.26e-06	0.00148	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—KNG1—pancreatitis	8.1e-06	0.00145	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—BDKRB2—pancreatitis	8.09e-06	0.00145	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CNR1—pancreatitis	7.94e-06	0.00142	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G1B—pancreatitis	7.88e-06	0.00141	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PRSS1—pancreatitis	7.8e-06	0.0014	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GCG—pancreatitis	7.67e-06	0.00137	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—XDH—pancreatitis	7.66e-06	0.00137	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—A2M—pancreatitis	7.61e-06	0.00136	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PRSS3—pancreatitis	7.4e-06	0.00132	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PNLIP—pancreatitis	7.4e-06	0.00132	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—KNG1—pancreatitis	7.36e-06	0.00132	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADH1B—pancreatitis	7.14e-06	0.00128	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SCT—pancreatitis	7.03e-06	0.00126	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGG—pancreatitis	7.03e-06	0.00126	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CASR—pancreatitis	7.03e-06	0.00126	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALDH2—pancreatitis	6.96e-06	0.00125	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CX3CL1—pancreatitis	6.89e-06	0.00123	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCL5—pancreatitis	6.77e-06	0.00121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MTNR1B—pancreatitis	6.7e-06	0.0012	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCK—pancreatitis	6.7e-06	0.0012	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—XDH—pancreatitis	6.63e-06	0.00119	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CNR2—pancreatitis	6.53e-06	0.00117	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—A2M—pancreatitis	6.53e-06	0.00117	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TACR1—pancreatitis	6.53e-06	0.00117	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CXCL8—pancreatitis	6.53e-06	0.00117	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCKAR—pancreatitis	6.43e-06	0.00115	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADH1B—pancreatitis	6.19e-06	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL5—pancreatitis	6.15e-06	0.0011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGA—pancreatitis	5.97e-06	0.00107	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—pancreatitis	5.97e-06	0.00107	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPL—pancreatitis	5.82e-06	0.00104	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G1B—pancreatitis	5.7e-06	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTHLH—pancreatitis	5.55e-06	0.000995	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SMO—pancreatitis	5.55e-06	0.000995	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CTRB2—pancreatitis	5.53e-06	0.00099	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—A2M—pancreatitis	5.5e-06	0.000986	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGB—pancreatitis	5.44e-06	0.000974	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—pancreatitis	5.42e-06	0.000971	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP3CA—pancreatitis	5.3e-06	0.000949	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GCG—pancreatitis	5.28e-06	0.000945	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SST—pancreatitis	5.08e-06	0.00091	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DUSP6—pancreatitis	5.04e-06	0.000902	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALDH2—pancreatitis	5.03e-06	0.000901	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G1B—pancreatitis	4.93e-06	0.000884	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FDX1—pancreatitis	4.79e-06	0.000858	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—BDKRB2—pancreatitis	4.78e-06	0.000856	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—A2M—pancreatitis	4.77e-06	0.000854	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CNR1—pancreatitis	4.69e-06	0.00084	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GCG—pancreatitis	4.53e-06	0.000811	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH4—pancreatitis	4.45e-06	0.000798	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALDH2—pancreatitis	4.36e-06	0.000781	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KNG1—pancreatitis	4.35e-06	0.000778	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	4.25e-06	0.000761	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—pancreatitis	4.24e-06	0.000759	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRSS1—pancreatitis	4.19e-06	0.00075	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPL—pancreatitis	4.14e-06	0.000742	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDGFA—pancreatitis	4e-06	0.000716	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRSS3—pancreatitis	3.97e-06	0.000711	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PNLIP—pancreatitis	3.97e-06	0.000711	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—pancreatitis	3.82e-06	0.000684	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCG—pancreatitis	3.81e-06	0.000683	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CXCL8—pancreatitis	3.69e-06	0.000661	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—pancreatitis	3.63e-06	0.000651	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—XDH—pancreatitis	3.56e-06	0.000638	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—pancreatitis	3.55e-06	0.000636	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SPP1—pancreatitis	3.37e-06	0.000603	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CXCL8—pancreatitis	3.35e-06	0.0006	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	3.34e-06	0.000599	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH1B—pancreatitis	3.32e-06	0.000595	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCG—pancreatitis	3.3e-06	0.000592	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—pancreatitis	3.2e-06	0.000574	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARG—pancreatitis	3.02e-06	0.000541	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—pancreatitis	2.99e-06	0.000536	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—pancreatitis	2.98e-06	0.000533	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—INS—pancreatitis	2.96e-06	0.000531	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—pancreatitis	2.72e-06	0.000487	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NRAS—pancreatitis	2.69e-06	0.000481	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G1B—pancreatitis	2.65e-06	0.000474	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—pancreatitis	2.59e-06	0.000464	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—A2M—pancreatitis	2.56e-06	0.000458	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—INS—pancreatitis	2.54e-06	0.000456	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—pancreatitis	2.5e-06	0.000448	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—pancreatitis	2.38e-06	0.000426	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDH2—pancreatitis	2.34e-06	0.000419	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—KRAS—pancreatitis	2.31e-06	0.000414	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARG—pancreatitis	2.19e-06	0.000391	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—INS—pancreatitis	2.14e-06	0.000384	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MDM2—pancreatitis	2.12e-06	0.000379	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCL8—pancreatitis	1.98e-06	0.000355	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HRAS—pancreatitis	1.97e-06	0.000352	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—pancreatitis	1.96e-06	0.000352	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CASP3—pancreatitis	1.89e-06	0.000339	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARG—pancreatitis	1.89e-06	0.000339	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—pancreatitis	1.88e-06	0.000337	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—INS—pancreatitis	1.86e-06	0.000332	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCG—pancreatitis	1.77e-06	0.000318	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—pancreatitis	1.72e-06	0.000308	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—pancreatitis	1.7e-06	0.000305	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NRAS—pancreatitis	1.59e-06	0.000284	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—pancreatitis	1.49e-06	0.000267	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—pancreatitis	1.48e-06	0.000264	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—pancreatitis	1.39e-06	0.000249	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KRAS—pancreatitis	1.37e-06	0.000245	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HRAS—pancreatitis	1.16e-06	0.000208	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—pancreatitis	1.11e-06	0.000199	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARG—pancreatitis	1.02e-06	0.000182	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INS—pancreatitis	9.96e-07	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—pancreatitis	9.13e-07	0.000164	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—pancreatitis	7.99e-07	0.000143	CbGpPWpGaD
